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Abstract:  24 
Clostridioides difficile R20291 is the most studied PCR-Ribotype 027 isolate. The two 25 
predominant lineages of this hypervirulent strain, however, exhibit substantive phenotypic 26 
differences and possess genomes that differ by a small number of nucleotide changes.  It 27 
is important that the source of R20291 is taken into account in research outcomes.  28 
 29 
Clostridioides difficile (formerly Clostridium difficile [1]) is the leading cause of hospital-30 
associated diarrhoea in the developed world. Its prevalence in recent years has been 31 
attributed to the emergence of hypervirulent strains, and in particular those belonging to 32 
BI/NAP1/PCR ribotype 027 (RT 027) which elaborate high titres of Toxin A/B, produce 33 
binary toxin and exhibit an increased propensity to form spores [2]. The first RT 027 strain 34 
to have its genome sequenced was strain R20291 [3] responsible for a major outbreak in 35 
2006 at Stoke Mandeville Hospital, UK. Consequently, R20291 has become one of the most 36 
studied laboratory strains of C. difficile.   37 
Full exploitation of clostridial genome sequence data has relied on the application of 38 
forward and reverse genetics tools [4], most notably ClosTron technology based on intron 39 
re-targeting [5]. Initial attempts to generate mutants in R20291, however, found that the 40 
effective transfer of the ClosTron plasmid was dependent on the R20291 stock used. 41 
Transfer was reproducibly possible using CRG0825, a stock of R20291 obtained by 42 
Nottingham’s Clostridia Research Group (CRG) from the UK Anaerobe reference unit 43 
(ARU), Cardiff, UK.  In comparison, transfer to a stock of R20291 (CRG2021) originating 44 
from the Brendon Wren laboratory at The London School of Hygiene and Tropical Medicine 45 
(LSHTM), was extremely ineffective. Consequently, the CRG0825 was taken forward in 46 
reverse genetic studies using the ClosTron and as the basis for the development of allelic-47 
exchange (AE) technology based on pyrE alleles [6]. As a result, CRG0825 and its ∆pyrE 48 
derivative have been widely distributed to research laboratories wishing to study R20291.  49 
3 
 
The inefficient nature of CRG2021 as a conjugative recipient is not confined to the ClosTron 50 
plasmid but affects a range of different vectors which are transferred to CRG0825 at rates 51 
that are an order of magnitude higher (Fig.S1). To shed light on this phenomenon the 52 
genome sequences and the phenotypes of the two strains were compared. A third R20291 53 
strain used by Novartis (CRG3661) was included for comparative purposes.  54 
Genomic DNA from all three strains was subjected to Illumina paired-end sequencing and 55 
the reads assembled and aligned with the reference genome sequence (Accession number:  56 
FN545816). This analysis identified six single nucleotide polymorphisms (SNPs) across all 57 
three strains that deviate from the reference sequence, alongside thirteen insertions and 58 
eleven deletions (Table 1). In addition to the mutations that were conserved across all 59 
three strains, CRG0825 possessed three deletions and two SNPs that were not present in 60 
the reference or CRG2021 sequence, whilst the CRG3661 possessed three unique SNPs 61 
(Table 1). CRG2091 did not possess any unique mutations compared with the reference 62 
genome sequence.  63 
Flagella likely play an important role in the conjugation process.  We had previously noted 64 
that CRG0825 carried a single, polar flagella [7]. A separate study suggested that 65 
CRG2091 was peritrichously flagellated [8]. These differences were confirmed here using 66 
Transmission Electron Microscopy (TEM) and extended to establish that CRG3661 was also 67 
peritrichously flagellated (Fig. 1c-e). Further analysis demonstrated that CRG0825 68 
exhibited an approximate 50% reduction in swimming motility relative to the other two 69 
strains (Fig. 1a).  Moreover, consistent with its reduced motility, strain CRG0825 was also 70 
found to show a greater propensity to form biofilm, as measured by a biomass formation 71 
using crystal violet [9], than strains CRG2021 and CRG3661 (Fig. 1b).  72 
Other studies have linked flagella-mediated motility with toxigenesis in C. difficile [10].  73 
Therein, inactivation of early-stage flagella genes led to increased toxin production 74 
corresponding with enhanced in vivo virulence, whilst inactivation of late-stage flagella 75 
genes had the opposite effect [11, 12]. Accordingly, we assessed the levels of toxin 76 
production in the three strains using a commercial ELISA kit on 72h filter-sterilised 77 
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supernatants as described previously [13]. An approximately 3.5-fold increase in toxin 78 
production was observed for the CRG0825 compared with the CRG2021 strain which 79 
produced around 22% less combined Toxin A/B than CRG3661 (Fig. 2a).   80 
Having established that genetic differences between the strains had affected the important 81 
virulence determinants of motility and toxin production, we tested to see whether the 82 
capacity to form endospores had been altered as spores represent a critical attribute of 83 
disease transmission.  Under the conditions tested it was established that the final titre of 84 
spores obtained from 96h onwards was the same regardless of the strain (Fig. 2b).  The 85 
first appearance of spores in cultures of CRG0825, however, was significantly delayed by 86 
some 24h compared to the other two strains (Fig. 2b). 87 
Finally, the growth performance of each strain was compared. On complex medium, 88 
CRG0825 grew to a lower optical density (OD) during the exponential and stationary 89 
growth phases than the CRG3661 or CRG2021 strains, where the greatest disparity was 90 
observed between the CRG0825 and CRG3661 (Fig S2a). Intriguingly, the observed 91 
difference was reversed when the strains were cultured on minimal medium containing 92 
either glucose, fructose or mannitol (1% w/v) as the primary carbohydrate source (Fig. 93 
S2b-d).   94 
The net result of our analysis was that the two R2091 strain CRG0825 and CRG2021 exhibit 95 
significant phenotypic differences. Aside from its greater efficiency as a recipient in 96 
conjugations with E. coli donor strains, CRG0825 was less motile and exhibited a greater 97 
propensity to form biofilm, as measured by a standard crystal violet assay. These 98 
differences may represent a consequence of its apparent possession of a single, polar 99 
flagella as opposed to the peritrichous flagella of CRG2021, as visualised under TEM.  100 
CRG0825 was also shown to produce higher levels of toxins, delayed sporulation and 101 
different growth characteristics to CRG2021 on rich and minimal media.  The cause of 102 
these phenotypic differences are undoubtedly the SNPs and Indels present in CRG0825.  103 
A number of pivotal questions emerge from these observations. 104 
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What are the specific causes of the observed changes in phenotype?  Many of the 105 
changes appear linked to flagella and motility, yet none of the five mutations in CRG0825 106 
reside directly within, or flank any known flagella genes, and are most likely impinging on 107 
the regulation of these processes. Moreover, regulation of flagella, toxin production and 108 
virulence are known to be linked in C. difficile [10-12].  Three of the four non-synonymous 109 
SNPs present in CRG0825 do indeed affect apparent regulatory genes, namely vncR, TCS 110 
HK and the anti-sigma factor rsbW.  Two of the three non-synonymous changes in 111 
CRG3661 are also in regulatory genes, codY and a gntR family regulator.  However, to pin 112 
down exactly which SNP(s) or Indels, are responsible for the observed phenotypic 113 
differences between CRG0825 and CRG2021, for instance, would require a considerable 114 
effort in which all combinations of mutation would need to be generated in allele 115 
replacement experiments during which the generation of additional changes would need 116 
to be excluded.   117 
How did these changes arise?  Following their discovery, correspondence with Val Hall 118 
at the ARU revealed that at the time R20291 was sent to Nottingham, it was routine ARU 119 
practice to “keep a small number of isolates that are used as internal lab controls on agar 120 
plates, sub-culturing weekly plate-to-plate and retrieving fresh cultures from the original 121 
vial periodically”.  The sequence presented here is from Nottingham’s -80° C, Master seed 122 
bank (red tube) prepared immediately on receipt of the strain in 2006.  We can conclude, 123 
that during the repeated subculture of the R20291 stock at the ARU in 2006, the 5 124 
described mutations arose. This practice of maintaining a stock plate no longer takes place 125 
at the ARU.  The consequences of subculturing have previously been noted in the case of 126 
the C. difficile strain 630, where deliberate, repeated subculture led to the emergence of 127 
two very different cell lines (630Δerm and 630E) carrying distinct SNPs, inversions and 128 
deletions and which exhibited differences in motility, spore formation and toxin production, 129 
as well as overall virulence in the hamster model of infection [14].     130 
What are the lessons to be learnt?  The take home message of this investigation is 131 
that stock cultures need to be appropriately maintained. At Nottingham, a traffic light 132 
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system is used to store bacterial cultures. Upon receipt of cultures, aliquots of cells (never 133 
single colonies) are used to inoculate an overnight which following addition of 10% glycerol 134 
is allocated to three 2 ml screwed capped tubes with a red, amber and green coloured cap 135 
insert and stored at -80° C. Red tubes remain untouched and are stored in a separate 136 
freezer.  Green tubes represent the working stock which may be restocked from the amber 137 
tube where necessary.    138 
The R20291 strain maintained at LSHTM has a genome sequence consistent with the 139 
sequence held at GenBank (Accession number:  FN545816). The differences listed in Table 140 
1 are common to all strains, and therefore likely represent errors in the original sequence. 141 
The strain CRG3661 began its journey at LSHTM and found its way to Novartis via the 142 
Trevor Lawley laboratory at the Sanger Institute, and thence to Nottingham.  It is not clear 143 
when its three mutations arose. The Nottingham CRG0825 apparently arose as a result of 144 
repeated subculture at the ARU.  145 
What is the way forward?  It is clearly advisable that the genome sequences of any 146 
stock culture of any bacterial strain stored in a laboratory should be confirmed, regardless 147 
of source, prior to use. This principal should equally apply to any mutant derivative of a 148 
strain made by whatever means, to ensure that additional SNPs/ Indels have not arisen. 149 
On the specific subject of studies dealing with R20291, it is important that experimentalists 150 
are aware of the differences between the strain lineages discussed here, and that the 151 
strain used is made clear in any meeting presentation or published article.  CRG0825 is a 152 
widely distributed strain, owing to its superior conjugative efficiencies and its usage in the 153 
development of AE mutagenesis technologies [6].  The absence of polymorphisms specific 154 
to CRG2021, however, suggests that this strain is the closest ancestor of the original 155 
R20291 clinical isolate.  Although the lack of a characterised uracil auxotroph, in addition 156 
to difficulties concerning conjugal transfer, formally reduced its attractiveness compared 157 
to CRG0825, recent advances that improve gene transfer frequencies [15, 16] and the 158 
advent of multiple CRISPR-Cas methodologies for use in C. difficile research [17-20], have 159 
improved the tractability of CRG2021 to genetic studies.  For those researchers who wish 160 
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to use AE technologies based on pyrE [6], the requisite auxotrophic uracil mutant of 161 
CRG2021 is available from www.plasmidvectors.com.  162 
 163 
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Table 1: Genomic mutations compared with the reference genome sequence for 243 
R02921.  244 
The region encompassing the mutation was aligned with multiple C. difficile genome 245 
sequences using NCBI Blastn. *Insertion here results in a frameshift mutation to a full-246 
length pseudogene encoding an 87 AA protein. This gene without mutation encodes only 247 
8 AAs. TCS-HC: Two-component system histidine kinase.  248 
 249 
Figure Legends 250 
Fig. 1: Motility, biofilm formation and Transmission electron microscopy of 251 
R20291 derivatives. a) The three derivatives of C. difficile R20291 were assessed for 252 
their motility characteristics using a swarming motility assay. Motility is represented by 253 
the distance travelled from the initial inoculum to the outermost edge of the ensuing halo 254 
following 48h incubation. b) The three R20291 derivatives were assessed for their 255 
propensity to form biofilms by means of a biofilm assay. Biofilm production is represented 256 
by the enumeration of crystal violet dye extracted from 120h broth cultures. Data 257 
represent the mean ±SD of three independent experiments. Statistical significance 258 
according to One-way ANOVA followed by the Dunnet’s multiple comparison test. 259 
P=**<0.01; P-***<0.001. Transmission electron microscopy analysis of c) CRG0825; d) 260 
CRG2091; e) CRG3661.  261 
 262 
Fig. 2: Toxin and sporulation profiles of R20291 derivatives. The three derivatives 263 
of R20291 were assessed for a) Their ability to produce and secrete toxin through a 264 
combined ELISA for TcdA and TcdB on sterile-filtered 72h supernatants b) Their ability to 265 
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form heat-resistant endospores (heat-resistant colony forming units HR-CFU/mL) across 266 
six time-points between 0 and 120h. Data represent the mean ±SD of three independent 267 
experiments. Statistical significance according to One-way ANOVA followed by the 268 





















































































































Table 1: Genomic mutations of the three R20291 stocks compared with the reference genome sequence.  
Position  Gene Locus Tag Type Reference ID Mutated ID AA substitution 
[1] Common to all three strains      
132924 met-tRNA  Insertion - A  
132939 met-tRNA  SNP G T  
132955 met-tRNA  SNP C A  
132958-59 met-tRNA  SNP TT CG  
143463 Intergenic  Insertion - A  
206399 Intergenic  Insertion - A  
581481 Intergenic  Insertion - A  
581488 Intergenic  Insertion - A  
581495 Intergenic  Insertion - A  
1564432 Intergenic  Deletion A -  
1568676 Ruberythrin CDR20291_1323 SNP C A Gln138Lys 
1578167 Intergenic  Deletion T -  
1578203 Intergenic  Insertion - A  
1592813 Intergenic  SNP A T  
1864417 Pseudogene CDR20291_1576 Insertion - T Ser7Frameshift* 
1899596 Intergenic  Deletion A -  
2235738 Membrane protein CDR20291_1913 Deletion T - Val83Frameshift 
2262060 Intergenic  Insertion - A  
2264190 Intergenic  Deletion T -  
2298111 Intergenic  Insertion - T  
2361948 Intergenic  SNP C A  
2361957 Intergenic  Insertion - A  
2367942 Intergenic  Insertion - T  
2578157 Intergenic  Deletion T -  
2674744 Intergenic  Deletion T -  
2680787 Intergenic  Insertion - T  
2772179 Pseudogene**  CDR20291_2368 Deletion T -  
3077986 Intergenic  Deletion A -  
3162098 Intergenic  Deletion T -  
3361915 Intergenic  Deletion A -  
[2] Specific to CRG0825      
9694 rsbW CDR20291_3551 SNP G T Gly82Val 
358260 rbsK CDR20291_0302 Deletion A - Met57Stop 
2077305 Intergenic (CDR20291_1777 to CDR20291_1778) Deletion C -  
2120669 vncR CDR20291_1806 SNP A G Asp202Gly 
2881467 TCS-HK***  CDR20291_2456 Deletion T - Leu434Stop 
[3] Specific to CRG3661      
1340128 codY CDR20291_1115 SNP T A Try146Asn 
3292465 gntR regulator  CDR20291_2781 SNP T C Ile58Met 
3472928 Intergenic (CDR20291_2929 to CDR20291_2928) SNP G A  
The region encompassing the mutation was aligned with multiple C. difficile genome sequences using NCBI Blastn. *Insertion here results in a frameshift 
mutation to a full-length pseudogene encoding an 87 AA protein. This gene without mutation encodes only 6 AAs. **Putative competence membrane 
protein ***TCS-HC: Two-component system histidine kinase. The gene resides immediately downstream of an adjacent gene (CDR20291_2457) encoding 
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R20291 (CRG0825) spo0A ClosTron mutant [1]. 
  
 23 
Experimental  24 
Bacterial Strains and Growth Conditions 25 
Strains were routinely cultured anaerobically at 37 °C in an anaerobic MACS1000 26 
workstation (Don Whitely, Yorkshire, UK) in BHIS (Brain Heart Infusion supplemented with 27 
yeast extract [5 mg.ml−1] and L-cysteine [0.1% w/v]) medium supplemented with d-28 
   
 
   
 
cycloserine (250 μg.ml−1), cefoxitin (8 μg.ml−1) and thiamphenicol (15 μg.ml−1) or Em 29 
(10 μg.ml−1) where appropriate.   30 
 31 
Comparative conjugations  32 
Conjugations of shuttle vectors into C. difficile R20291 were performed as described in 33 
[2]. Briefly, E. coli CA434 donor strains harbouring either pMTL82151, pMTL83151 or 34 
pMTL84151 were grown overnight in LB supplemented with chloramphenicol and 35 
kanamycin. From which, aliquots (1ml) were pelleted, washed in PBS and resuspended in 36 
200 µl of C. difficile R20291 cultures grown anaerobically overnight in BHIS broth. The 37 
resulting conjugal mixtures were spotted onto BHIS plates lacking antibiotics and 38 
incubated anaerobically for 24h. Subsequent growth was resuspended in PBS (500µl) and 39 
spread onto BHIS plates supplemented with d-cycloserine and cefoxitin, both with and 40 
without thiamphenicol. After 72h, Thiamphenicol (Tm) resistant (R) CFU.ml-1 and total C. 41 
difficile CFU.ml-1 values were determined from the subsequent growth of C. difficile R20291 42 
strains in the presence (TmR) or absence (total) of thiamphenicol. Conjugation efficiency 43 
was calculated as the TmR CFU.ml-1 divided by total C. difficile CFU.ml-1.  44 
24h growth curve 45 
The growth characteristics of C. difficile R02921 was assessed by manual growth curve. 46 
Therein, colonies of C. difficile R20291 were subcultured into fresh BHIS broth in an 47 
Anaerobic Work Station (Don Whitley, UK), at 37°C with an anaerobic atmosphere 48 
comprising 80% N2, 10% H2 and 10% CO2. The resultant cultures were then diluted 1/100 49 
in fresh BHIS and grown to an optical density value (OD600nm) of 0.2-0.5. This generated 50 
replicates of each strain with similar starting OD values for downstream growth 51 
assessment. Once target OD values had been reached, the cultures were diluted 1/100 in 52 
fresh medium incubated for 24h. 1ml of sample was taken for each replicate at hourly 53 
intervals which was then assessed for its optical density using a Novaspec II 54 
spectrophotometer (Geminibv, Netherlands).  55 
   
 
   
 
 56 
Motility assay 57 
The motility of C. difficile R20291 derivatives was assessed by swimming motility assays 58 
as previously described [3]. Therein, single colonies of R20291 were isolated using a 59 
toothpick and stabbed onto the centre of semi-solid BHIS plate containing 0.3% (w/v) 60 
agar. Following 48h incubation as described above, the diameter of the ensuing halo was 61 
measured. Motility is represented as the distance between the centremost and outermost 62 
points of detected colonisation (cm).  63 
  64 
Crystal Violet, Biofilm Assay 65 
The assay was undertaken essentially as described by Dapa and co-workers [4]. A starter 66 
culture of C. difficile was prepared by inoculating fresh BHIs broth containing 0.1M glucose 67 
with an overnight culture of the desired strain in a 1:100 dilution. A 1ml aliquot of this 68 
culture added to each well of a 24-well Tissue culture plate (Costar,USA) and incubated 69 
anaerobically for 120h. Plates were pre-reduced in the anaerobic cabinet for 48h prior to 70 
use. To avoid liquid evaporation, each plate was wrapped in parafilm.  Following 71 
incubation, wells were washed with PBS and the plate allowed to dry for 10m. The biofilm 72 
was stained with 1ml of filter-sterilised 0.2% (w/v) crystal violet solution per well and 73 
incubated for 30m at 37°C under anaerobic conditions. The staining solution was removed 74 
and the wells were washed twice with PBS. The plate was removed from the anaerobic 75 
cabinet and 1ml methanol was added to the wells for the removal of the dye from the 76 
biofilm and it was incubated for 30m at room temperature. The methanol extracted dye 77 
was diluted 1:1, 1:10 and 1:100 and the absorbance A570 was measured with Ultrospec 78 
500 pro spectrophotometer. 79 
 80 
Sporulation assay 81 
   
 
   
 
Cultures were generated for each strain with similar staring OD values as described for 82 
the 24h growth curve. For the sporulation assay, cultures were incubated for a 120h 83 
period. Samples were taken at 24h intervals which were heated at 65°C for 30m in order 84 
to eradicate vegetative cells and diluted 1x10-1-1x10-8 before plating onto BHIS 85 
supplemented with 0.1% taurocholate germinant. Spores were then enumerated for each 86 
R20291 derivative alongside a ClosTron insertional mutant for the master regulator of 87 
sporulation spo0A [1]. 88 
 89 
Detection of combined TcdA and TcdB  90 
Combined TcdA and TcdB was detected as previously described [5]. Cultures of each strain 91 
were collected after 72h, the OD measured, and normalised to the lowest OD value. 92 
Normalised samples were centrifuged and the supernatant passed through a 0.22µm filter 93 
and frozen at -20°C until required (<1 week). Thawed samples were diluted 1X101 – 1X108 94 
in sterile PBS and processed for ELISA quantification of total TcdA and TcdB using a C. 95 
DIFFICILE Tox A/B II detections kit (TechLab, USA) according to the manufacturer’s 96 
instructions. Absorbance values were converted into toxin concentration by determining 97 
the R2 value of the assay’s standard curve by running a range of defined combined TcdA 98 
and TcdB toxin standards from 0-125ng/ml (The Native Antigen Company). 99 
 100 
Genome Sequencing 101 
Chromosomal DNA of each strain was prepared and subjected to Illumina paired-end 102 
sequencing by DeepSeq (University of Nottingham) using the MiSeq v3 600 platform. 103 
Paired reads were trimmed, before mapping the trimmed reads to the reference genome 104 
sequence for R20291 (Accession number:  FN545816) using the quality-based variant 105 
detection workflow from CLC Genomics Workbench (Qiagen, Germantown, USA). The 106 
software was then used to identify single nucleotide variations (SNVs), insertions and 107 
deletions compared with the reference genome sequence. Sequencing reads were 108 
   
 
   
 
deposited to the NCBI Sequencing Reads Archive with the Bioproject accession 109 
PRJNA689976 and the following individual accession numbers: CRG2021 (SRR13366486); 110 
CRG0825 (SRR13366485); CRG03661 (SRR13366484).  111 
 112 
Supplementary Figures  113 
  114 
 115 
Fig S1: Comparative conjugation efficiencies of plasmid transfer from E. coli 116 
CA434 into C. difficile R20291 stocks CRG0825 and CRG2021.  Conjugations from 117 
E. coli CA434 strains harbouring the indicated shuttle vectors, differing only in the Gram-118 
positive replicon present, into C. difficile R20291 CRG2021 (grey bars) and CRG0825 119 
(black bars) were performed as indicated in Materials and Methods. Conjugation efficiency 120 
was calculated as thiamphenicol resistant CFU.ml-1 divided by the total recipient C. difficile 121 
R20291 CFU.ml-1. Data represent the mean ±SD of three independent experiments. 122 
Statistical significance was determined using multiple unpaired t-tests. P=****<0.0001; 123 
ns= not significant.  124 
 125 
   
 






Figure S2: Comparison of growth characteristics between the three derivatives 130 
of R20291. R02921 strains were grown for 24h in a) BHIS broth; b) CDMM 1% (w/v) 131 
glucose; c) CDMM 1% fructose; d) CDMM 1% mannitol. Data points indicate the mean 132 
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